BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 821096)

  • 1. Evaluation of scintigraphic and roentgenologic studies in Paget's disease under treatment.
    Vellenga CJ; Pauwels EK; Bijvoet OL; Hosking DJ
    Radiol Clin (Basel); 1976; 45(2-4):292-301. PubMed ID: 821096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal scintimaging and radiography in the diagnosis and management of Paget's disease.
    Wellman HN; Schauwecker D; Robb JA; Khairi MR; Johnston CC
    Clin Orthop Relat Res; 1977; (127):55-62. PubMed ID: 410575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels.
    Ang G; Feiglin D; Moses AM
    Endocr Pract; 2003; 9(4):280-3. PubMed ID: 14561571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal distribution and biochemical parameters of Paget's disease.
    Meunier PJ; Salson C; Mathieu L; Chapuy MC; Delmas P; Alexandre C; Charhon S
    Clin Orthop Relat Res; 1987 Apr; (217):37-44. PubMed ID: 3103964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of ethane-hydroxy-diphosphonate in the treatment of Paget's disease].
    Morales Piga A; García Vadillo A; Rodríguez García A; Elena Ibáñez A; Castro Beiras JM; Rodríguez Torrás M
    Rev Clin Esp; 1985 Oct; 177(6):273-7. PubMed ID: 3936134
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
    Alexandre CM; Chapuy MC; Vignon E; Edouard C; Johnston CC; Meunier PJ
    Clin Orthop Relat Res; 1983 Apr; (174):193-205. PubMed ID: 6403270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone scintigraphy in Paget's disease treated with combined calcitonin and diphosphonate (EHDP).
    Vellenga CJ; Pauwels EK; Bijvoet OL; Hosking DJ; Frijlink WB
    Metab Bone Dis Relat Res; 1982; 4(2):103-11. PubMed ID: 6815413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
    Stein I; Shapiro B; Ostrum B; Beller ML
    Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative bone scintigraphy in Paget's disease treated with APD.
    Vellenga CJ; Pauwels EK; Bijvoet OL; Harinck HI; Frijlink WB
    Br J Radiol; 1985 Dec; 58(696):1165-72. PubMed ID: 3842627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
    Jaeger P; Bischoff-Delaloye A; Burckhardt P
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of monostotic Paget's disease: effects of bisphosphonate.
    Hoshiro M; Harada T; Iwai H; Miyatake T; Nishimura A; Ohno Y; Aoki N
    Endocr J; 2003 Aug; 50(4):385-92. PubMed ID: 14599111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M; Khairi A; Johnston C
    Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
    Sieghart S
    Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical feature and calcitonin therapy on Paget's disease of bone (author's transl)].
    Dokoh S; Morita R; Yamamoto I; Fukunaga M; Hamanaka D; Torizuka K
    Nihon Seikeigeka Gakkai Zasshi; 1979 Aug; 53(8):937-47. PubMed ID: 574527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of anatomic arteriovenous shunts in Paget's disease of bone.
    Rhodes BA; Greyson ND; Hamilton CR; White RI; Giargiana FA; Wagner HN
    N Engl J Med; 1972 Oct; 287(14):686-9. PubMed ID: 5055417
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of Paget's disease of bone].
    Mimura K
    Nihon Seikeigeka Gakkai Zasshi; 1985 Aug; 59(8):751-61. PubMed ID: 3936894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
    Al Nofal AA; Altayar O; BenKhadra K; Qasim Agha OQ; Asi N; Nabhan M; Prokop LJ; Tebben P; Murad MH
    Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paget's disease of the bone: a report of three cases.
    Bhatt K; Balakrishnan C; Mangat G; Bajan K; Ashavaid T; Joshi VR
    J Assoc Physicians India; 2006 Jul; 54():571-4. PubMed ID: 17089908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintigraphic aspects of the recurrence of treated Paget's disease of bone.
    Vellenga CJ; Pauwels EK; Bijvoet OL; Frijlink WB
    J Nucl Med; 1981 Jun; 22(6):510-7. PubMed ID: 7229723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternate calcitonin and etidronate disodium therapy for Paget's bone disease.
    Perry HM; Droke DM; Avioli LV
    Arch Intern Med; 1984 May; 144(5):929-33. PubMed ID: 6424594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.